# OnCo record lns8801 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lns8801/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lns8801" ;
  schema:name "LNS8801"@en ;
  schema:description "LNS8801 is an experimental investigational agent whose form is not stated in the registry from Linnaeus Therapeutics in phase 3 trials for melanoma, aimed at Estrogen receptor (ERα)."@en ;
  schema:url <https://onco.cc/drugs/lns8801/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=LNS8801> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "not stated (registered as a drug or biological on ClinicalTrials.gov)" ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:companies <https://onco.cc/companies/linnaeus-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06624644/>, <https://onco.cc/trials/nct04130516/> .